National Vision Holdings, Inc. Cost-method Investments, Other than Temporary Impairment
National Vision Holdings, Inc. (EYE) reported Cost-method Investments, Other than Temporary Impairment of $1.00 million for the 12-month period ending 2017-12-30, per its 10-K filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2018-03-08
- National Vision Holdings, Inc. cost-method investments, other than temporary impairment for the quarter ending 2017-07-01 was $1.00M.
- National Vision Holdings, Inc. cost-method investments, other than temporary impairment for fiscal 2017 was $1.00M.
| Period end | Cost-method Investments, Other than Temporary Impairment 3 month | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|---|
| 2017-12-30 | $1.00M 10-K · filed 2018-03-08 | |
| 2017-07-01 | $1.00M 10-Q · filed 2017-12-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |